Dr. Lamia Alomair
Dr. Alomair is currently the Head of A.I. and Bioinformatics at King Abdullah International Medical Research Center (KAIMRC), and an affiliated faculty member at George Mason University.
Dr. Alomair is one of the first Saudi women to obtain a Bachelor Degree in Computer Science, from King Saud University, and was quick to join the Saudi National Guard Health Affairs (NGHA). As only one of two Saudi female employees in her department, her hard work and dedication helped her overcome various obstacles in her early career. This in turn had a huge impact on the role of women in Healthcare and technology projects.
She started working at the NGHA as a Programmer and Database Specialist, and was later promoted to Database Administrator and Manager of Human Resource Management System, working on trending topics such as Big Data, and related initiatives and projects. She then decided to further her career in the newly emerging field of Health Informatics. She obtained a Master degree in Health Informatics from King Saud Bin Abdul-Aziz University for Health Sciences in 2007.
Dr.Alomair then applied her skills to many I.T. projects at the NGHA and even participated in a few national initiatives in the field of Health Informatics. Her initiatives lead her towards more advance field of computational Bioinformatics. At this point she decided to focus more on this promising new field. In 2017, Dr. Alomair earned her PhD in Bioinformatics and Computational Biology from George Mason University, USA.
In recent years, Dr. Alomair has been examining the rapidly evolving field of Artificial Intelligence (A.I.), exploring its current and potential applications in healthcare sectors. She organized with passionate a successful AI & Bioinformatics symposium in April 2021 to increase awareness and improve skill in AI among young professionals.
Dr.Alomair has excellent communication skills and actively involving in building various strategies for collaboration nationally and internationally.
She is an active supporter and enabler in the fields of both A.I. and Big Data, and regularly utilizes her exposure to healthcare officials and healthcare projects, both locally and internationally, to promote their advancements and implementations.